1	INTRODUCTION	24
1.1	STUDY OBJECTIVES	24
1.2	MARKET DEFINITION	24
1.2.1	INCLUSIONS & EXCLUSIONS	25
1.3	MARKET SCOPE	26
1.3.1	MARKETS COVERED	26
FIGURE 1	MEDICAL RADIATION SHIELDING MARKET SEGMENTATION	26
1.3.2	GEOGRAPHIC SCOPE	26
1.3.3	YEARS CONSIDERED	27
1.4	CURRENCY	27
1.5	LIMITATIONS	27
1.6	MARKET STAKEHOLDERS	28
1.7	SUMMARY OF CHANGES	28
2	RESEARCH METHODOLOGY	29
2.1	RESEARCH DATA	29
FIGURE 2	RESEARCH DESIGN	29
2.1.1	SECONDARY DATA	30
2.1.1.1	Secondary sources	30
2.1.2	PRIMARY DATA	31
FIGURE 3	PRIMARY SOURCES	31
2.1.2.1	Key data from primary sources	32
2.1.2.2	Key industry insights	33
2.1.2.3	Breakdown of primary interviews	33
FIGURE 4	BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS	33
FIGURE 5	BREAKDOWN OF PRIMARY INTERVIEWS	34
2.2	MARKET SIZE ESTIMATION	34
2.2.1	GROWTH FORECAST	36
FIGURE 6	CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS	36
FIGURE 7	TOP-DOWN APPROACH	37
2.3	MARKET BREAKDOWN AND DATA TRIANGULATION	38
FIGURE 8	DATA TRIANGULATION METHODOLOGY	38
2.4	MARKET SHARE ANALYSIS	39
2.5	ASSUMPTIONS	39
2.6	INDICATORS AND ASSUMPTIONS	40
2.7	RISK ASSESSMENT	40
TABLE 1	RISK ASSESSMENT	40
2.8	IMPACT OF RECESSION: MEDICAL RADIATION SHIELDING MARKET	41
3	EXECUTIVE SUMMARY	42
FIGURE 9	MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)	42
FIGURE 10	MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2023 VS. 2028 (USD MILLION)	43
FIGURE 11	MEDICAL RADIATION SHIELDING MARKET FOR RADIATION THERAPY SHIELDING, BY TYPE, 2023 VS. 2028 (USD MILLION)	44
FIGURE 12	MEDICAL RADIATION SHIELDING MARKET FOR DIAGNOSTIC SHIELDING, BY TYPE, 2023 VS. 2028 (USD MILLION)	45
FIGURE 13	MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)	46
FIGURE 14	GEOGRAPHICAL SNAPSHOT OF MEDICAL RADIATION SHIELDING MARKET	47
4	PREMIUM INSIGHTS	48
4.1	MEDICAL RADIATION SHIELDING MARKET OVERVIEW	48
FIGURE 15	GROWING GLOBAL INCIDENCE OF CANCER TO DRIVE MARKET GROWTH	48
4.2	NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION AND COUNTRY, 2022	49
FIGURE 16	DIAGNOSTIC SHIELDING HELD LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022	49
4.3	MEDICAL RADIATION SHIELDING MARKET: GEOGRAPHIC SNAPSHOT	50
FIGURE 17	CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD	50
5	MARKET OVERVIEW	51
5.1	INTRODUCTION	51
5.2	MARKET DYNAMICS	51
FIGURE 18	MEDICAL RADIATION SHIELDING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES	51
5.2.1	DRIVERS	52
5.2.1.1	Increasing use of nuclear medicine and radiation therapy for diagnosis and treatment	52
5.2.1.2	Growing incidence of cancer	52
TABLE 2	NUMBER OF NEW CANCER CASES, 2020–2040	53
TABLE 3	INCREASING INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)	53
5.2.1.3	Increasing safety awareness among people working in radiation-prone environments	53
5.2.1.4	Growth in number of PET/CT scans	54
TABLE 4	CT SCANNERS INSTALLED, BY COUNTRY, 2019 VS. 2021 (PER MILLION INHABITANTS)	54
TABLE 5	CT SCAN PROCEDURAL VOLUME, BY COUNTRY, 2019 VS. 2021 (PER 1,000 INHABITANTS)	54
5.2.1.5	Increasing number of trained radiologic technologists	54
TABLE 6	METROPOLITAN AREAS IN US WITH HIGH EMPLOYMENT LEVELS AMONG RADIOLOGY TECHNOLOGISTS AND TECHNICIANS	55
5.2.2	RESTRAINTS	55
5.2.2.1	Lack of adequate healthcare infrastructure	55
5.2.2.2	Shortage of skilled oncologists/radiologists	55
5.2.3	OPPORTUNITIES	56
5.2.3.1	Rising healthcare expenditure across developing countries	56
5.2.3.2	Increasing public-private investments in cancer research	56
5.2.3.3	Technological advancements in radiation detection	57
5.2.4	CHALLENGES	57
5.2.4.1	High cost of lead in manufacturing radiation accessories	57
5.3	VALUE CHAIN ANALYSIS	58
FIGURE 19	VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES	58
5.4	SUPPLY CHAIN ANALYSIS	59
FIGURE 20	DIRECT DISTRIBUTION—PREFERRED STRATEGY FOR PROMINENT COMPANIES	59
5.5	PORTER’S FIVE FORCES ANALYSIS	60
5.5.1	THREAT OF NEW ENTRANTS	60
5.5.2	THREAT OF SUBSTITUTES	60
5.5.3	BARGAINING POWER OF BUYERS	60
5.5.4	BARGAINING POWER OF SUPPLIERS	60
5.5.5	INTENSITY OF COMPETITIVE RIVALRY	60
5.6	KEY STAKEHOLDERS & BUYING CRITERIA	61
5.6.1	KEY STAKEHOLDERS IN BUYING PROCESS	61
FIGURE 21	INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS, CLINICS, AND ASCS AND DIAGNOSTIC CENTERS	61
TABLE 7	INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP END USERS (%)	61
5.6.2	BUYING CRITERIA	62
FIGURE 22	KEY BUYING CRITERIA FOR HOSPITALS, CLINICS, AND ASCS AND DIAGNOSTIC CENTERS	62
TABLE 8	KEY BUYING CRITERIA FOR HOSPITALS, CLINICS, AND ASCS AND DIAGNOSTIC CENTERS	62
5.7	REGULATORY LANDSCAPE	63
5.7.1	NORTH AMERICA	63
5.7.2	EUROPE	64
5.7.3	ASIA PACIFIC	64
5.8	TRADE ANALYSIS	64
TABLE 9	IMPORT DATA FOR HS CODE 903010, BY COUNTRY, 2018–2022 (USD THOUSAND)	64
TABLE 10	EXPORT DATA FOR HS CODE 903010, BY COUNTRY, 2018–2022 (USD THOUSAND)	65
5.9	ECOSYSTEM ANALYSIS	65
FIGURE 23	KEY PLAYERS OPERATING IN MEDICAL RADIATION SHIELDING MARKET	65
TABLE 11	ROLE IN ECOSYSTEM	66
5.10	PATENT ANALYSIS	67
5.11	KEY CONFERENCES & EVENTS IN 2023–2024	68
TABLE 12	LIST OF CONFERENCES & EVENTS	68
5.12	PRICING ANALYSIS	69
5.12.1	AVERAGE SELLING PRICE OF KEY PRODUCTS	69
TABLE 13	PRICE RANGE OF KEY PRODUCTS IN MEDICAL RADIATION SHIELDING MARKET (USD)	69
5.13	TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES	70
5.14	TECHNOLOGY ANALYSIS	70
6	MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT	72
6.1	INTRODUCTION	73
TABLE 14	MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	73
6.2	MRI SHIELDING PRODUCTS	74
6.2.1	INCREASING INSTALLATION BASE OF MRI SCANNERS WORLDWIDE TO BOOST MARKET	74
TABLE 15	MEDICAL RADIATION SHIELDING MARKET FOR MRI SHIELDING PRODUCTS, BY REGION, 2021–2028 (USD MILLION)	74
6.3	LEAD-LINED GLASS, DOORS, AND WINDOWS	75
6.3.1	ABILITY OF LEAD-LINED GLASS TO PROTECT PERSONNEL FROM UNNECESSARY RADIATION EXPOSURE TO PROPEL GROWTH	75
TABLE 16	MEDICAL RADIATION SHIELDING MARKET FOR LEAD-LINED GLASS, DOORS, AND WINDOWS, BY REGION, 2021–2028 (USD MILLION)	75
6.4	LEAD-LINED DRYWALLS & PLYWOOD	76
6.4.1	GROWING DEMAND FOR LEAD-LINED PLYWOOD FOR HEAVIER LEAD SHIELDING REQUIREMENTS TO BOOST MARKET	76
TABLE 17	MEDICAL RADIATION SHIELDING MARKET FOR LEAD-LINED DRYWALLS & PLYWOOD, BY REGION, 2021–2028 (USD MILLION)	76
6.5	SHIELDS, BARRIERS, AND BOOTHS	77
6.5.1	INCREASING NUMBER OF DIAGNOSTIC IMAGING CENTERS TO DRIVE GROWTH	77
TABLE 18	MEDICAL RADIATION SHIELDING MARKET FOR SHIELDS, BARRIERS, AND BOOTHS, BY REGION, 2021–2028 (USD MILLION)	78
6.6	LEAD SHEETS	78
6.6.1	CORROSION RESISTANCE ASSOCIATED WITH LEAD SHEETS TO FUEL DEMAND	78
TABLE 19	MEDICAL RADIATION SHIELDING MARKET FOR LEAD SHEETS, BY REGION, 2021–2028 (USD MILLION)	79
6.7	LEAD BRICKS	79
6.7.1	RESISTANCE TO DAMAGE TO DRIVE ADOPTION OF LEAD BRICKS	79
TABLE 20	MEDICAL RADIATION SHIELDING MARKET FOR LEAD BRICKS, BY REGION, 2021–2028 (USD MILLION)	80
6.8	HIGH-DENSITY CONCRETE BLOCKS	80
6.8.1	SIGNIFICANT ATTENUATION PROVIDED BY HIGH-DENSITY CONCRETE BLOCKS TO BOOST DEMAND	80
TABLE 21	MEDICAL RADIATION SHIELDING MARKET FOR HIGH-DENSITY CONCRETE BLOCKS, BY REGION, 2021–2028 (USD MILLION)	81
6.9	X-RAY ROOMS	81
6.9.1	DEVELOPMENT OF NEW MATERIALS AS ALTERNATIVES TO LEAD TO CREATE GROWTH OPPORTUNITIES	81
TABLE 22	MEDICAL RADIATION SHIELDING MARKET FOR X-RAY ROOMS, BY REGION, 2021–2028 (USD MILLION)	82
6.10	LEAD CURTAINS & SCREENS	82
6.10.1	GREATER SHIELDING CAPABILITY OF THICK LEAD SCREENS TO FAVOR MARKET GROWTH	82
TABLE 23	MEDICAL RADIATION SHIELDING MARKET FOR LEAD CURTAINS & SCREENS, BY REGION, 2021–2028 (USD MILLION)	83
6.11	LEAD ACRYLIC	83
6.11.1	SUPERIOR VISUAL CLARITY AND HIGH LIGHT TRANSMISSION OF LEAD ACRYLIC TO FUEL ADOPTION	83
TABLE 24	MEDICAL RADIATION SHIELDING MARKET FOR LEAD ACRYLIC, BY REGION, 2021–2028 (USD MILLION)	84
7	MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION	85
7.1	INTRODUCTION	86
TABLE 25	MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)	86
7.2	RADIATION THERAPY SHIELDING	86
TABLE 26	RADIATION THERAPY SHIELDING MARKET, BY REGION, 2021–2028 (USD MILLION)	86
TABLE 27	RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	87
7.2.1	LINEAR ACCELERATORS	87
7.2.1.1	Growing adoption of linear accelerators to drive market growth	87
TABLE 28	MEDICAL RADIATION SHIELDING MARKET FOR LINEAR ACCELERATORS, BY REGION, 2021–2028 (USD MILLION)	88
7.2.2	MULTIMODALITY IMAGING	88
7.2.2.1	Recent advances in multimodality imaging to boost market	88
TABLE 29	MEDICAL RADIATION SHIELDING MARKET FOR MULTIMODALITY IMAGING, BY REGION, 2021–2028 (USD MILLION)	88
7.2.3	CYCLOTRONS	89
7.2.3.1	Ability of cyclotrons to produce high yields of short half-life, neutron-deficient radioisotopes to favor market growth	89
TABLE 30	MEDICAL RADIATION SHIELDING MARKET FOR CYCLOTRONS, BY REGION, 2021–2028 (USD MILLION)	90
7.2.4	BRACHYTHERAPY	90
7.2.4.1	Ability of brachytherapy to deliver low-dose radiation to drive market	90
TABLE 31	MEDICAL RADIATION SHIELDING MARKET FOR BRACHYTHERAPY, BY REGION, 2021–2028 (USD MILLION)	91
7.2.5	PROTON THERAPY	91
7.2.5.1	Non-invasive and non-threatening nature of proton therapy to fuel adoption	91
TABLE 32	MEDICAL RADIATION SHIELDING MARKET FOR PROTON THERAPY, BY REGION, 2021–2028 (USD MILLION)	92
7.3	DIAGNOSTIC SHIELDING	92
TABLE 33	DIAGNOSTIC SHIELDING MARKET, BY REGION, 2021–2028 (USD MILLION)	92
TABLE 34	DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	93
7.3.1	CT SCANNERS	93
7.3.1.1	Rising demand for CT systems from hospitals, clinics, and ASCs to drive market	93
TABLE 35	MEDICAL RADIATION SHIELDING MARKET FOR CT SCANNERS, BY REGION, 2021–2028 (USD MILLION)	94
7.3.2	X-RAY IMAGING	94
7.3.2.1	Consistent high quality of images provided by digital imaging to boost demand	94
TABLE 36	MEDICAL RADIATION SHIELDING MARKET FOR X-RAY IMAGING, BY REGION, 2021–2028 (USD MILLION)	95
7.3.3	MRI	95
7.3.3.1	Wide use of MRI in hospitals for medical diagnosis and staging of diseases to boost growth	95
TABLE 37	MEDICAL RADIATION SHIELDING MARKET FOR MRI, BY REGION, 2021–2028 (USD MILLION)	96
7.3.4	NUCLEAR IMAGING	96
7.3.4.1	Recent advances in nuclear medicine to increase number of nuclear medicine procedures globally	96
TABLE 38	MEDICAL RADIATION SHIELDING MARKET FOR NUCLEAR MEDICINE, BY REGION, 2021–2028 (USD MILLION)	97
8	MEDICAL RADIATION SHIELDING MARKET, BY END USER	98
8.1	INTRODUCTION	99
TABLE 39	MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)	99
8.2	HOSPITALS, ASCS, AND CLINICS	99
8.2.1	INCREASING NUMBER OF INTERNAL RADIATION THERAPY PROCEDURES TO BOOST MARKET GROWTH	99
TABLE 40	MEDICAL RADIATION SHIELDING MARKET FOR HOSPITALS, ASCS, AND CLINICS, BY REGION, 2021–2028 (USD MILLION)	100
8.3	DIAGNOSTIC CENTERS	100
8.3.1	GROWING NUMBER OF DIAGNOSTIC CENTERS TO DRIVE GROWTH	100
TABLE 41	MEDICAL RADIATION SHIELDING MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2021–2028 (USD MILLION)	101
9	MEDICAL RADIATION SHIELDING MARKET, BY REGION	102
9.1	INTRODUCTION	103
TABLE 42	MEDICAL RADIATION SHIELDING MARKET, BY REGION, 2021–2028 (USD MILLION)	103
9.2	NORTH AMERICA	103
9.2.1	NORTH AMERICA: RECESSION IMPACT	103
FIGURE 24	NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET SNAPSHOT	104
TABLE 43	NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)	104
TABLE 44	NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	105
TABLE 45	NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)	105
TABLE 46	NORTH AMERICA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	106
TABLE 47	NORTH AMERICA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	106
TABLE 48	NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)	106
9.2.2	US	107
9.2.2.1	US to dominate North American medical radiation shielding market during forecast period	107
TABLE 49	US: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	108
TABLE 50	US: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)	108
TABLE 51	US: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	109
TABLE 52	US: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	109
TABLE 53	US: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)	109
9.2.3	CANADA	110
9.2.3.1	Increasing number of radiography procedures to support market growth in Canada	110
TABLE 54	CANADA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	111
TABLE 55	CANADA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)	111
TABLE 56	CANADA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	112
TABLE 57	CANADA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	112
TABLE 58	CANADA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)	112
9.3	EUROPE	113
9.3.1	EUROPE: RECESSION IMPACT	113
TABLE 59	EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)	114
TABLE 60	EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	114
TABLE 61	EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)	115
TABLE 62	EUROPE: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	115
TABLE 63	EUROPE: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	115
TABLE 64	EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)	116
9.3.2	GERMANY	116
9.3.2.1	Growing geriatric population and increasing radiography procedures in Germany to favor market growth	116
TABLE 65	GERMANY: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	117
TABLE 66	GERMANY: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)	117
TABLE 67	GERMANY: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	118
TABLE 68	GERMANY: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	118
TABLE 69	GERMANY: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)	118
9.3.3	FRANCE	119
9.3.3.1	Large number of CT procedures performed to fuel market	119
TABLE 70	FRANCE: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	119
TABLE 71	FRANCE: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)	120
TABLE 72	FRANCE: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	120
TABLE 73	FRANCE: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	120
TABLE 74	FRANCE: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)	121
9.3.4	UK	121
9.3.4.1	Increasing government initiatives and support to aid market	121
TABLE 75	UK: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	122
TABLE 76	UK: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)	122
TABLE 77	UK: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	123
TABLE 78	UK: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	123
TABLE 79	UK: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)	123
9.3.5	REST OF EUROPE	124
TABLE 80	REST OF EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	124
TABLE 81	REST OF EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)	124
TABLE 82	REST OF EUROPE: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	125
TABLE 83	REST OF EUROPE: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	125
TABLE 84	REST OF EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)	125
9.4	ASIA PACIFIC	126
9.4.1	ASIA PACIFIC: RECESSION IMPACT	126
FIGURE 25	ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET SNAPSHOT	127
TABLE 85	ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)	128
TABLE 86	ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	128
TABLE 87	ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)	129
TABLE 88	ASIA PACIFIC: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	129
TABLE 89	ASIA PACIFIC: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	129
TABLE 90	ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)	130
9.4.2	CHINA	130
9.4.2.1	Large patient pool and rising healthcare spending to aid market	130
TABLE 91	CHINA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	131
TABLE 92	CHINA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)	131
TABLE 93	CHINA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	132
TABLE 94	CHINA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	132
TABLE 95	CHINA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)	132
9.4.3	JAPAN	133
9.4.3.1	Rising awareness about radiation exposure to drive market	133
TABLE 96	JAPAN: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	133
TABLE 97	JAPAN: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)	134
TABLE 98	JAPAN: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	134
TABLE 99	JAPAN: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	134
TABLE 100	JAPAN: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)	135
9.4.4	INDIA	135
9.4.4.1	Favorable government policies and healthcare infrastructure to support market	135
TABLE 101	INDIA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	136
TABLE 102	INDIA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)	136
TABLE 103	INDIA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	137
TABLE 104	INDIA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	137
TABLE 105	INDIA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)	137
9.4.5	REST OF ASIA PACIFIC	138
TABLE 106	INCIDENCE OF CANCER IN REST OF ASIA PACIFIC, 2020 VS. 2040	138
TABLE 107	REST OF ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	139
TABLE 108	REST OF ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)	139
TABLE 109	REST OF ASIA PACIFIC: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	140
TABLE 110	REST OF ASIA PACIFIC: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	140
TABLE 111	REST OF ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)	140
9.5	REST OF THE WORLD (ROW)	141
9.5.1	REST OF THE WORLD (ROW): RECESSION IMPACT	141
TABLE 112	REST OF THE WORLD: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	142
TABLE 113	REST OF THE WORLD: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)	143
TABLE 114	REST OF THE WORLD: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	143
TABLE 115	REST OF THE WORLD: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)	143
TABLE 116	REST OF THE WORLD: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)	144
10	COMPETITIVE LANDSCAPE	145
10.1	OVERVIEW	145
TABLE 117	OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL RADIATION SHIELDING MARKET	145
10.2	MARKET RANKING	146
TABLE 118	TOP 3 COMPANIES IN MEDICAL RADIATION SHIELDING MARKET	146
10.3	COMPANY EVALUATION QUADRANT FOR TOP PLAYERS	146
10.3.1	STARS	147
10.3.2	EMERGING LEADERS	147
10.3.3	PARTICIPANTS	147
10.3.4	PERVASIVE PLAYERS	147
FIGURE 26	MEDICAL RADIATION SHIELDING MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS, 2022	148
10.4	COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS	149
10.4.1	PROGRESSIVE COMPANIES	149
10.4.2	STARTING BLOCKS	149
10.4.3	RESPONSIVE COMPANIES	149
10.4.4	DYNAMIC COMPANIES	149
FIGURE 27	MEDICAL RADIATION SHIELDING MARKET: COMPANY EVALUATION MATRIX FOR SMES/STARTUPS, 2022	150
10.5	COMPETITIVE BENCHMARKING	151
TABLE 119	MEDICAL RADIATION SHIELDING MARKET: DETAILED LIST OF KEY STARTUPS/SMES	151
10.6	COMPANY FOOTPRINT ANALYSIS	151
TABLE 120	FOOTPRINT ANALYSIS OF COMPANIES	151
TABLE 121	REGIONAL FOOTPRINT ANALYSIS OF COMPANIES	152
TABLE 122	PRODUCT FOOTPRINT ANALYSIS OF COMPANIES	153
10.7	COMPETITIVE SCENARIO	154
10.7.1	DEALS	154
TABLE 123	KEY DEALS, JANUARY 2020–MAY 2023	154
10.7.2	OTHER DEVELOPMENTS	155
TABLE 124	OTHER KEY DEVELOPMENTS, JANUARY 2020–MAY 2023	155
11	COMPANY PROFILES	156
11.1	KEY PLAYERS	156
(Business overview, Products offered, Recent Developments, MNM view)*
11.1.1	ETS-LINDGREN (AN ESCO TECHNOLOGIES COMPANY)	156
TABLE 125	ETS-LINDGREN (AN ESCO TECHNOLOGIES COMPANY): BUSINESS OVERVIEW	156
FIGURE 28	ETS-LINDGREN (AN ESCO TECHNOLOGIES COMPANY): COMPANY SNAPSHOT (2022)	157
11.1.2	BIODEX (A PART OF MIRION TECHNOLOGIES, INC.)	161
TABLE 126	BIODEX (A PART OF MIRION TECHNOLOGIES, INC.): BUSINESS OVERVIEW	161
FIGURE 29	BIODEX (A PART OF MIRION TECHNOLOGIES, INC.): COMPANY SNAPSHOT (2022)	162
11.1.3	NELCO WORLDWIDE	165
TABLE 127	NELCO WORLDWIDE: BUSINESS OVERVIEW	165
11.1.4	GAVEN INDUSTRIES, INC.	167
TABLE 128	GAVEN INDUSTRIES, INC.: BUSINESS OVERVIEW	167
11.1.5	RADIATION PROTECTION PRODUCTS, INC.	168
TABLE 129	RADIATION PROTECTION PRODUCTS, INC.: BUSINESS OVERVIEW	168
11.1.6	MARSHIELD (A DIVISION OF MARS METAL CO.)	170
TABLE 130	MARSHIELD (A DIVISION OF MARS METAL CO.): BUSINESS OVERVIEW	170
11.1.7	RAY-BAR ENGINEERING CORP.	172
TABLE 131	RAY-BAR ENGINEERING CORP.: BUSINESS OVERVIEW	172
11.1.8	AMRAY MEDICAL	174
TABLE 132	AMRAY MEDICAL: BUSINESS OVERVIEW	174
11.1.9	A&L SHIELDING	175
TABLE 133	A&L SHIELDING: BUSINESS OVERVIEW	175
11.1.10	GLOBAL PARTNERS IN SHIELDING, INC.	177
TABLE 134	GLOBAL PARTNERS IN SHIELDING, INC.: BUSINESS OVERVIEW	177
11.1.11	VERITAS MEDICAL SOLUTIONS LLC	178
TABLE 135	VERITAS MEDICAL SOLUTIONS, LLC: BUSINESS OVERVIEW	178
11.1.12	ALIMED, INC.	179
TABLE 136	ALIMED, INC.: BUSINESS OVERVIEW	179
11.1.13	PROTECH MEDICAL	180
TABLE 137	PROTECH MEDICAL: BUSINESS OVERVIEW	180
11.1.14	GLOBE COMPOSITE SOLUTIONS LLC	181
TABLE 138	GLOBE COMPOSITE SOLUTIONS LLC: BUSINESS OVERVIEW	181
11.1.15	ULTRARAY	182
TABLE 139	ULTRARAY: BUSINESS OVERVIEW	182
11.1.16	MARS METAL COMPANY	183
TABLE 140	MARS METAL COMPANY: BUSINESS OVERVIEW	183
11.1.17	NUCLEAR LEAD CO.	185
TABLE 141	NUCLEAR LEAD CO.: BUSINESS OVERVIEW	185
11.1.18	NUCLEAR SHIELDS B.V.	186
TABLE 142	NUCLEAR SHIELDS B.V.: BUSINESS OVERVIEW	186
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
11.2	OTHER PLAYERS	188
11.2.1	SHIELDING INTERNATIONAL INC.	188
11.2.2	BAR-RAY PRODUCTS, INC.	188
11.2.3	XENA SHIELD	189
11.2.4	BURLINGTON MEDICAL	190
11.2.5	SIMAD SRL	190
11.2.6	EUROPEAN EMC PRODUCTS	191
12	APPENDIX	192
12.1	DISCUSSION GUIDE	192
12.2	KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL	197
12.3	CUSTOMIZATION OPTIONS	199
12.4	RELATED REPORTS	199
12.5	AUTHOR DETAILS	200
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer



 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			